Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

81 - 90 of 793 results found

One-year follow-up of the immunogenicity and safety of a primary series of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Final report of a phase I/II randomized controlled trial

Date
Saturday, February 03, 2024 - 4:00 AM
Description
BACKGROUND: In the interim report of this phase I/II randomized, placebo-controlled trial in Japanese adults, a two-dose primary series of NVX-CoV2373 (5 µg SARS-CoV-2 recombinant nanoparticle spike protein [rS]; 50 µg Matrix-M) administered 21 days

Optimal entropic properties of SARS-CoV-2 RNA sequences

Date
Thursday, February 01, 2024 - 4:00 AM
Description
The reaction of the scientific community against the COVID-19 pandemic has generated a huge (approx. 10⁶ entries) dataset of genome sequences collected worldwide and spanning a relatively short time window. These unprecedented conditions together